CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,232,854
- in 4 filings, $918K under 10b5-1 plans
Net −$1,232,854. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-03-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +273,692 | 273,692 | ||
| 2018-03-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +116,392 | 116,392 | ||
| 2018-03-14 | Shandell Jason B. President and General Counsel | Option exercise | +400 | $11.79 | $5K | 217,348 |
| 2018-03-14 | Shandell Jason B. President and General Counsel | Sale | −400 | $20.45 | $8K | 216,948 |
| 2018-03-14 | Shandell Jason B. President and General Counsel | Option exercise · Employee Stock Option (right to buy) | −400 | 5,300 | ||
| 2018-03-13 | PETERS WILLIAM J CFO, SVP & Treasurer | Option exercise | +19,801 | $11.33 | $224K | 98,115 |
| 2018-03-13 | PETERS WILLIAM J CFO, SVP & Treasurer | Sale | −19,801 | $20.10 | $398K | 78,314 |
| 2018-03-13 | PETERS WILLIAM J CFO, SVP & Treasurer | Option exercise · Employee Stock Option (right to buy) | −19,801 | 99,400 | ||
| 2018-03-13 | Shandell Jason B. President and General Counsel | Option exercise | +300 | $11.79 | $4K | 217,248 |
| 2018-03-13 | Shandell Jason B. President and General Counsel | Sale | −300 | $20.45 | $6K | 216,948 |
| 2018-03-13 | Shandell Jason B. President and General Counsel | Option exercise · Employee Stock Option (right to buy) | −300 | 5,700 | ||
| 2018-01-26 | Shandell Jason B. President and General Counsel | Sale | −9,966 | $19.56 | $195K | 216,948 |
| 2018-01-25 | Shandell Jason B. President and General Counsel | Sale | −8,661 | $19.26 | $167K | 226,914 |
| 2017-12-19 | Gerst Diane G. EVP, QA & Regulatory Affairs | Sale | −523 | $19.48 | $10K | 30,164 |
| 2017-12-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Option exercise | +639,584 | $12.02 | $7.7M | 2,537,431 |
| 2017-12-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Shares withheld for taxes | −524,266 | $19.30 | $10.1M | 2,013,165 |
| 2017-12-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Option exercise | +373,091 | $12.02 | $4.5M | 1,636,469 |
| 2017-12-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Shares withheld for taxes | −305,823 | $19.30 | $5.9M | 1,330,646 |
| 2017-12-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −639,584 | 319,791 | ||
| 2017-12-15 | Zhang Jack Y. CEO & Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −373,091 | 186,545 |
Page 57 of 81 · 1,602 trades